<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101585685</journal-id>
<journal-id journal-id-type="pubmed-jr-id">40353</journal-id>
<journal-id journal-id-type="nlm-ta">Autism Open Access</journal-id>
<journal-id journal-id-type="iso-abbrev">Autism Open Access</journal-id>
<journal-title-group>
<journal-title>Autism-open access</journal-title>
</journal-title-group>
<issn pub-type="epub">2165-7890</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27928515</article-id>
<article-id pub-id-type="pmc">5137782</article-id>
<article-id pub-id-type="doi">10.4172/2165-7890.1000190</article-id>
<article-id pub-id-type="manuscript">EMS70523</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial Dysfunction in Autism Spectrum Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Siddiqui</surname>
<given-names>Maheen F</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elwell</surname>
<given-names>Clare</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnson</surname>
<given-names>Mark H</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Centre for Brain and Cognitive Development, Birkbeck College, London, UK</aff>
<aff id="A2"><label>2</label>Medical Physics and Biomedical Engineering, University College London, London, UK</aff>
<author-notes>
<corresp id="CR1"><label>*</label><bold>Corresponding author:</bold> Siddiqui MF, Centre for Brain and Cognitive Development, Birkbeck College, London, United Kingdom, <email>maheen.faisal.14@ucl.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>5</issue>
<elocation-id>1000190</elocation-id>
<permissions>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Autism spectrum disorders (ASD) are classified as neurodevelopmental disorders characterised by diminished social communication and interaction. Recently, evidence has accrued that a significant proportion of individuals with autism have concomitant diseases such as mitochondrial disease and abnormalities of energy generation. This has therefore led to the hypothesis that autism may be linked to mitochondrial dysfunction. We review such studies reporting decreased activity of mitochondrial electron transport chain (ETC) complexes and reduced gene expression of mitochondrial genes, in particular genes of respiratory chain complexes, in individuals with autism. Overall, the findings support the hypothesis that there is an association of ASD with impaired mitochondrial function; however, many of the studies have small sample sizes and there is variability in the techniques utilised. There is therefore a vital need to utilise novel imaging techniques, such as near-infrared spectroscopy, that will allow non-invasive measurement of metabolic markers for neuronal activity such as cytochrome c oxidase, in order to better establish the link between autism and mitochondrial dysfunction.</p>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>Mitochondrial dysfunction</kwd>
<kwd>Mitochondrial health</kwd>
<kwd>Energy metabolism</kwd>
<kwd>Electron transport chain</kwd>
<kwd>Mitochondrial deficiency</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>